Southern Surgicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.54 M
- Company Age 27 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 25.13%
- Profit Growth 39.13%
- Ebitda 321.35%
- Net Worth 3.07%
- Total Assets 0.18%
About Southern Surgicals
Southern Surgicals Private Limited (SSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 May 1997 and has a history of 27 years and nine months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.54 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Maheswari, Krishna Maheswari, Raghav Maheswari, and One other member serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33112KA1997PTC022220
- Company No.
022220
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 1997
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Southern Surgicals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Maheswari  | Additional Director | 08-Apr-2016 | Current |
| Krishna Maheswari | Director | 09-May-1997 | Current |
| Raghav Maheswari | Director | 25-Aug-2010 | Current |
| Manju Maheswari | Director | 29-Oct-2005 | Current |
Financial Performance of Southern Surgicals.
Southern Surgicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.13% increase. The company also saw a substantial improvement in profitability, with a 39.13% increase in profit. The company's net worth moved up by a moderate rise of 3.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Southern Surgicals?
In 2023, Southern Surgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sataytej Commercial Co Private LimitedKrishna Maheswari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Southern Surgicals?
Unlock and access historical data on people associated with Southern Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Southern Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Southern Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
